Full throttle for these 3 stocks as uptrends break new ground

Published: November 25 2022, 12:20 GMT+0

Full throttle for these 3 stocks as uptrends break new ground

GoHealth, Inc., MICT, Inc., Mirati Therapeutics, Inc. are the ones to notice as they lead stocks on an uptrend.

Leading equity indices in the US rose as Nasdaq closed the day at 11,300, having gained 0.99%. S&P 500 ended the session at 4,027.26 after a 0.59% gain.

What is an uptrend?

A trend is the overall direction of a market or an asset's trading price over a certain period. An uptrend is when the price is generally pointing upwards; there can be certain periods of time when the price falls, yet the trend remains in an upward direction.

Ascends for 8 days (+2,270%): GoHealth gains 2.03% within $8.77 to $9.39 daily range

Having gone up $8.47 over the past 8 days, GoHealth stayed on track Wednesday: generally flat but with a slight bullish bias, GoHealth ranged between $8.77 and $9.39 before closing higher at $9.03. The day's trading volume totalled 130,803 shares — below the 21-day average of 1.33 million.

Micronet Enertec Technologies's uptrend continues, up to $1.21: Bullish mood lifts Micronet Enertec Technologies to session high of $1.22

Micronet Enertec Technologies is on a 15 day uptrend, gaining a total of 86.15%. Wednesday's session pointed in the same direction — the mobile computing device maker rose as high as $1.22 before giving up its gains and dropping back to $1.21 before the close on Wednesday. Daily trading volume (1.30 million shares) was above the current multiday average of 301,440.

Mirati Therapeutics continues climbing, currently at $95.85: Mirati Therapeutics bulls in charge as markets close for Thanksgiving

Wednesday continued on the same track for Mirati Therapeutics — an influx of buyers helped the US oncology company to end the session higher around $95.85, while establishing a $86.38 to $95.95 session range Wednesday. Mirati Therapeutics is on a 12 day bullish run gaining $26.67 (61.26%). Daily trading volume (2.83 million shares) was higher than the current multiday average of 1.33 million.

Mirati Therapeutics is currently trading with a market cap of $5.52 billion with an average daily volume of 1.33 million shares. The biotechnology developer has recovered 119.89% since descending to a significant low of $39.16 around 5 months ago. So far in 2022, it has performed better than the Nasdaq by 1.67%. Mirati Therapeutics last reported revenue of $5.43 million with an EPS of $-3.09.

Back